5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases
申请人:BeiGene, Ltd.
公开号:US10882856B2
公开(公告)日:2021-01-05
Disclosed herein are 5 or 8-substituted imidazo [1, 5-a] pyridines and pharmaceutical compositions comprising at least one such 5 or 8-substituted imidazo [1, 5-a] pyridines, processes for the preparation thereof and the use thereof in therapy. Disclosed herein are certain 5 or 8-substituted imidazo [1, 5-a] pyridines that can be useful for inhibiting indoleamine 2, 3-dioxygenase and/or tryptophane 2, 3-dioxygenase and for treating diseases or disorders mediated thereby.
本文公开了5或8-取代咪唑并[1,5-a]吡啶和包含至少一种此类5或8-取代咪唑并[1,5-a]吡啶的药物组合物、其制备工艺及其在治疗中的应用。本文公开的某些 5 或 8-取代咪唑并[1,5-a]吡啶可用于抑制吲哚胺 2,3-二氧 化酶和/或色氨酸 2,3-二氧 化酶,并可用于治疗由其介导的疾病或紊乱。